Neuropathological consequences of delivering an adenoviral vector in the rat brain
- 30 March 2004
- journal article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (7) , 740-750
Abstract
Background Adenoviruses have many advantages as vehicles for gene delivery to the central nervous system (CNS) and retrograde transport of vectors to axonally linked sites has been postulated as a method for targeting neurons in remote brain regions. To investigate optimisation of this we injected different doses of vector and have documented the neuropathological side effects. Methods Increasing doses of a first‐generation adenoviral vector, expressing the lacZ gene, were inoculated in the rat striatum and β‐galactosidase expression was examined at the primary and secondary sites. Subsequently, at the highest dose of vector, transgene expression, the inflammatory response, tyrosine hydroxylase (TH) expression and the rotational behaviour of animals were studied over time. Results When a high dose of an adenoviral vector was delivered to the rat striatum, high levels of transgene expression were seen at 5 days in the injection site and in the substantia nigra. Smaller doses gave lower levels of expression with little expression detectable in the substantia nigra. At later time points, with the high dose, a marked reduction in transgene expression was detected and was accompanied by cytopathic damage, a strong inflammatory response and animal weight loss. This was associated with depletion in TH levels and abnormal motor behaviour in animals. Conclusions Neuropathological damage in the dopaminergic system, caused by high doses of adenoviral vectors, has not previously been documented. To minimise damage and prolong transgene expression, it is important that the dose of vectors to be delivered is carefully optimised. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 50 references indexed in Scilit:
- Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced areaGene Therapy, 2003
- Regulation of CRE‐mediated transcription in mouse brain by amphetamineSynapse, 2003
- Regulation of gene expression for neurotransmitters during adaptation to hypoxia in oxygen‐sensitive neuroendocrine cellsMicroscopy Research and Technique, 2002
- Neurotropism and Retrograde Axonal Transport of a Canine Adenoviral Vector: A Tool for Targeting Key Structures Undergoing Neurodegenerative ProcessesMolecular Therapy, 2002
- Preexisting Antiadenoviral Immunity Is Not a Barrier to Efficient and Stable Transduction of the Brain, Mediated by Novel High-Capacity Adenovirus VectorsHuman Gene Therapy, 2001
- Acute Direct Adenoviral Vector Cytotoxicity and Chronic, but Not Acute, Inflammatory Responses Correlate with Decreased Vector-Mediated Transgene Expression in the BrainMolecular Therapy, 2001
- Induction of DNA fragmentation and HSP72 immunoreactivity by adenovirus-mediated gene transfer in normal gerbil hippocampus and ventricleJournal of Neuroscience Research, 1998
- Prolonged In Vivo Gene Expression Driven by a Tyrosine Hydroxylase Promoter in a Defective Herpes Simplex Virus Amplicon VectorHuman Gene Therapy, 1996
- Specific Patterns of Defective HSV-1 Gene Transfer in the Adult Central Nervous System: Implications for Gene TargetingExperimental Neurology, 1994
- Alteration in tyrosine hydroxylase, glutamic acid decar☐ylase and choline acetyltransferase in basal ganglia following herpes simplex virus inoculation in rat neostriatumBrain Research, 1979